Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2001 1
2002 1
2006 2
2009 2
2010 2
2011 5
2012 4
2013 1
2014 3
2015 2
2016 2
2017 2
2020 3
2021 2
2022 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
[Pharmacological targets in multiple sclerosis].
Varo-Sánchez GM, Cuenca-López MD, Fernández-Fernández Ó, Joaquín J. Varo-Sánchez GM, et al. Among authors: fernandez fernandez o. Rev Neurol. 2011 Jul 1;53(1):27-34. Rev Neurol. 2011. PMID: 21678322 Free article. Review. Spanish.
Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016.
García Merino A, Ramón Ara Callizo J, Fernández Fernández O, Landete Pascual L, Moral Torres E, Rodríguez-Antigüedad Zarrantz A. García Merino A, et al. Among authors: fernandez fernandez o. Neurologia. 2017 Mar;32(2):113-119. doi: 10.1016/j.nrl.2016.02.026. Epub 2016 May 6. Neurologia. 2017. PMID: 27157522 Free article. Review. English, Spanish.
[Treatment of vertigo].
Fernández Fernández O. Fernández Fernández O. Rev Clin Esp. 2001 May;201(5):268-71. doi: 10.1016/s0014-2565(01)70816-8. Rev Clin Esp. 2001. PMID: 11458798 Spanish. No abstract available.
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.
Meca-Lallana JE, Fernández-Prada M, García Vázquez E, Moreno Guillén S, Otero Romero S, Rus Hidalgo M, Villar Guimerans LM, Eichau Madueño S, Fernández Fernández Ó, Izquierdo Ayuso G, Álvarez Cermeño JC, Arnal García C, Arroyo González R, Brieva Ruiz L, Calles Hernández C, García Merino A, González Plata M, Hernández Pérez MÁ, Moral Torres E, Olascoaga Urtaza J, Oliva-Nacarino P, Oreja-Guevara C, Ortiz Castillo R, Oterino A, Prieto González JM, Ramió-Torrentá L, Rodríguez-Antigüedad A, Saiz A, Tintoré M, Montalbán Gairin X. Meca-Lallana JE, et al. Among authors: fernandez fernandez o. Neurologia (Engl Ed). 2022 Oct;37(8):615-630. doi: 10.1016/j.nrleng.2019.11.001. Epub 2020 Mar 12. Neurologia (Engl Ed). 2022. PMID: 36195374 Free article.
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.
Meca-Lallana JE, Fernández-Prada M, García Vázquez E, Moreno Guillén S, Otero Romero S, Rus Hidalgo M, Villar Guimerans LM, Eichau Madueño S, Fernández Fernández Ó, Izquierdo Ayuso G, Álvarez Cermeño JC, Arnal García C, Arroyo González R, Brieva Ruiz L, Calles Hernández C, García Merino A, González Platas M, Hernández Pérez MÁ, Moral Torres E, Olascoaga Urtaza J, Oliva-Nacarino P, Oreja-Guevara C, Ortiz Castillo R, Oterino A, Prieto González JM, Ramió-Torrentá L, Rodríguez-Antigüedad A, Saiz A, Tintoré M, Montalbán Gairin X. Meca-Lallana JE, et al. Among authors: fernandez fernandez o. Neurologia (Engl Ed). 2020 Jan 25;37(8):615-630. doi: 10.1016/j.nrl.2019.11.003. Print 2022 Oct. Neurologia (Engl Ed). 2020. PMID: 31987648 Free article. English, Spanish.
[Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)].
Fernandez-Fernandez O, Alvarez-Cermeno JC, Arbizu-Urdiain T, Arroyo-Gonzalez R, Arnal-Garcia C, Casanova-Estruch B, Calles-Hernandez MC, Coret-Ferrer F, Comabella M, Garcia-Merino JA, de Las Heras V, Izquierdo G, Meca-Lallana JE, Munoz-Garcia D, Olascoaga J, Oreja-Guevara C, Prieto JM, Rodriguez-Antiguedad A, Tintore M, Montalban X; Grupo Post-ECTRIMS. Fernandez-Fernandez O, et al. Rev Neurol. 2011 Mar 1;52(5):289-99. Rev Neurol. 2011. PMID: 21341224 Free article. Review. Spanish.
[Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)].
Fernández-Fernández O, Alvarez-Cermeño JC, Arbizu-Urdiain T, Arroyo-González R, Arnal-García C, Casanova-Estruch B, Calles-Hernández MC, Coret-Ferrer F, Comabella M, García-Merino JA, de Las Heras V, Izquierdo G, Meca-Lallana JE, Muñoz-García D, Olascoaga J, Oreja-Guevara C, Prieto JM, Rodríguez-Antigüedad A, Tintoré M, Montalban X; Grupo Post-ECTRIMS. Fernández-Fernández O, et al. Rev Neurol. 2011 Feb 16;52(4):227-38. Rev Neurol. 2011. PMID: 21312169 Free article. Review. Spanish.
31 results